Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies

Editorial

Alastair MacLennan et al. Climacteric. 2005 Mar.

. 2005 Mar;8(1):1-2.

doi: 10.1080/13697130500042292.

No abstract available

Comment on

KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N. Harman SM, et al. Climacteric. 2005 Mar;8(1):3-12. doi: 10.1080/13697130500042417. Climacteric. 2005. PMID: 15804727
Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
Peeyananjarassri K, Baber R. Peeyananjarassri K, et al. Climacteric. 2005 Mar;8(1):13-23. doi: 10.1080/13697130400012288. Climacteric. 2005. PMID: 15804728 Review.
Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E, Ayton R, Darling G, Farrell E, Murkies A, O'Neill S, Kirkegard Y, Fraser IS. Weisberg E, et al. Climacteric. 2005 Mar;8(1):83-92. doi: 10.1080/13697130500087016. Climacteric. 2005. PMID: 15804736 Clinical Trial.